Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can prophylactic application of immunoglobulin decrease radiotherapy-induced oral mucositis?

S Mose1, I A Adamietz, F Saran

  • 1Department of Radiation Oncology, Johann Wolfgang Goethe Universität, Frankfurt am Main, Germany.

American Journal of Clinical Oncology
|August 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility and Outcomes of Craniospinal Irradiation and Concurrent Daily Carboplatin in Children and Adults With High-risk Central Nervous System Tumours.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Predicting Survival with Brain Metastases in the Stereotactic Radiosurgery Era: are Existing Prognostic Scores Still Relevant? Or Can we do Better?

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Number of musculoskeletal pain sites leads to increased long-term healthcare contacts and healthcare related costs - a Danish population-based cohort study.

BMC health services research·2021
Same author

Hypofractionated Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Tumours in Children and Young Adults.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Same author

Challenges to Treating Older Glioblastoma Patients: the Influence of Clinical and Tumour Characteristics on Survival Outcomes.

Clinical oncology (Royal College of Radiologists (Great Britain))·2017
Same author

Infant formula containing galacto-and fructo-oligosaccharides and <i>Bifidobacterium breve</i> M-16V supports adequate growth and tolerance in healthy infants in a randomised, controlled, double-blind, prospective, multicentre study.

Journal of nutritional science·2017
Same journal

Care Patterns and Gastric Cancer-Related Outcomes in Patients With Pathogenic/Likely Pathogenic Germline CDH1 Variants: A 14-Year Single-Center Analysis.

American journal of clinical oncology·2026
Same journal

Upper Extremity Lymphedema​​​: Performance of a Risk Prediction Model in Women Undergoing Surgery for Breast Cancer.

American journal of clinical oncology·2026
Same journal

Executive Summary of the American Radium Society (ARS) Appropriate Use Criteria (AUC) for the Use of Radiation in the Prevention and Treatment of Heterotopic Ossification (HO).

American journal of clinical oncology·2026
Same journal

Stereotactic Body Radiation Therapy Combined With Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma: A Comprehensive Single-Arm Meta-Analysis Approach.

American journal of clinical oncology·2026
Same journal

Emergence of Single-Week Adjuvant Radiation Therapy for Early-Stage Breast Cancer in the United States.

American journal of clinical oncology·2026
Same journal

Early Versus Delayed Pancreatic Enzyme Replacement Therapy After Pancreatic Cancer Surgery: A Real-World Cohort Study.

American journal of clinical oncology·2026
See all related articles

Prophylactic immunoglobulin may reduce radiation-induced mucositis in head and neck cancer patients, especially when combined with chemotherapy. However, its efficacy is less pronounced than therapeutic applications.

Area of Science:

  • Oncology
  • Immunology

Background:

  • Radiation therapy for head and neck cancer often causes oral mucositis.
  • Therapeutic immunoglobulin has shown success in treating mucositis.

Purpose of the Study:

  • To investigate the efficacy of prophylactic immunoglobulin in preventing radiation-induced mucositis.
  • To compare mucositis severity in patients receiving standard care versus immunoglobulin plus standard care.

Main Methods:

  • 42 head and neck cancer patients undergoing radiation (with or without chemotherapy) were studied.
  • Control group received panthenol and nystatin.
  • Intervention group received panthenol, nystatin, and weekly human immunoglobulin.
  • Mucositis severity was assessed three times weekly.

Related Experiment Videos

Main Results:

  • A trend towards less severe mucositis was observed in the immunoglobulin group (not significant).
  • Statistically significant reduction in mean mucositis degree was found in the overall group (p=0.031) and in patients receiving chemoradiation.
  • No significant effect was noted in patients treated with radiation alone.

Conclusions:

  • Prophylactic immunoglobulin appears to mitigate radiation-induced mucositis, particularly in chemoradiation patients.
  • The clinical efficacy of prophylactic immunoglobulin in this study was less evident compared to therapeutic use.